Skip to main content

Table 2 Imaging and laboratory data of the patients based on the genotype of c.-582A > G variant

From: Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy

 

AA/AG

GG

Male Gender

34.4%

50%

Age

 Mean ± SD

34.8 ± 6.1

31.5 ± 2.7

TX (day)

 Mean ± SD

18.4 ± 4.6

17.2 ± 3.0

Hb (g/dl)

 Mean ± SD

9.8 ± 1.2

8.7 ± 1.7

Hct (%)

 Mean ± SD

29.5 ± 3.2

29.3 ± 3.6

Ferritin (ng/ml)

 Median (25–75%)

1648.0 (773.8–3189.5)

2064.5 (1638.0–5518.0)

T2*MRI-H (ms)

 Mean ± SD

25.5 ± 9.1

17.3 ± 13.7

T2*MRI-L (ms)

 Mean ± SD

7.9 ± 9.3

2.2 ± 0.2

  1. TX, transfusion intervals; Hb, hemoglobin; Hct, hematocrit; T2*MRI-H, heart iron concentration evaluated by MRI (normal rang is > 20 ms); T2*MRI-L, Liver iron concentration evaluated by MRI (normal range is > 6.3 ms)